In vitro activity of ribostamycin against Prototheca sp.
The in vitro activity of ribostamycin against algae of the genus Prototheca was evaluated by minimum inhibitory concentration (MIC) studies on solid media. Concentrations of 4 mcg/ml were required to inhibit 100% of the P. zopfii strains; 16 mcg/ml inhibited 100% of the P. stagnora strains and 95% of the P. wickerhamii strains. These values are inferior to plasma concentrations obtained after injection of ribostamycin. It is likely that this antibiotic could be effective in the treatment of protothecosis in man.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D011525:Prototheca / Q000187:drug effects*; D012271:Ribostamycin / Q000494:pharmacology*; D013045:Species Specificity
D000900:Anti-Bacterial Agents; D012271:Ribostamycin